Application of two novel electrical restitution-based ECG markers of ventricular arrhythmia to patients with nonischemic cardiomyopathy.

William B NicolsonMatthew I SmithZakariyya ValiNilesh J SamaniGhulam Andre Ng

Published in: Pacing and clinical electrophysiology : PACE (2021)

R2I2≥ 1.03 + PERS ≥ 1.21 may predict VA/death in patients with cardiomyopathies. R2I2 ≥ 1.03 + PERS ≥ 1.21 have the potential to play an important role in SCD risk stratification in cardiomyopathies but their validity should be confirmed in a larger study.

Keyphrases

heart failure
catheter ablation
left ventricular
heart rate
blood pressure
risk assessment
human health